Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study
収録刊行物
-
- International Journal of Clinical Oncology
-
International Journal of Clinical Oncology 26 (1), 154-162, 2020-10-16
Springer Science and Business Media LLC
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360572092858196736
-
- ISSN
- 14377772
- 13419625
-
- データソース種別
-
- Crossref
- KAKEN